(1)
COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA. Mediterr J Hematol Infect Dis 2021, 13 (1), Page e2021034. https://doi.org/10.4084/MJHID.2021.034.